AI/ML Innovations Inc.
Category: AI in Healthcare
A company focused on acquiring and advancing Artificial Intelligence and Machine Learning technologies, primarily targeting the digital healthcare sector. AI/ML Innovations Inc. was founded in 2019. The company is led by Paul Duffy. Based in Vancouver, Canada. Team size: 1-10. Total funding raised: $1.63M. Latest round: Post-IPO Equity (Private Placement). Key investors include Not Publicly Disclosed.
- Founded
- 2019
- Headquarters
- Vancouver, Canada
- Team size
- 1-10
- Total funding
- $1.63M
Value proposition
To provide transformative healthcare management solutions and precision support delivery across the health continuum by leveraging AI/ML, cloud computing, and digital platforms to enhance recovery outcomes and promote healthy living.
Products and solutions
Health Gauge: A personal health monitoring and management system., Tech2Health: Digital health software and wearable technologies., General health-tech products and solutions.
Unique value
The company's strategy is to identify and acquire emerging digital health and wellness companies that utilize AI and ML, then foster their growth and development to build a portfolio of innovative healthcare solutions.
Target customer
Healthcare providers, caregivers, patients, and healthcare professionals.
Industries served
Digital Health, Healthcare AI, Telemedicine
Technology advantage
Leveraging AI and machine learning neural networks for non-invasive medicine and personal health monitoring. Business advantage resides in strategic acquisitions and partnerships enabling rapid integration and scaling of innovative technologies.
How they differentiate
AI/ML Innovations Inc. operates as a strategic acquirer and incubator of companies in the AI/ML sector, focusing on synergistic AI-driven healthcare technologies rather than a single product.
Main competitors
Fitbit (Google), Garmin, Teladoc Health
Key partnerships
Health Gauge (Subsidiary), Tech2Health (Subsidiary)
Notable customers
Partnerships with US-based healthcare and senior living providers (Tech2Health subsidiary)., Enterprise-level partnerships deploying digital health solutions.
Major milestones
Acquisition of key technology subsidiaries Health Gauge and Tech2Health., Listing on the Canadian Securities Exchange (CSE) under ticker AIML., Completed $1.55M private placement in 2024 to fund growth., Expansion of digital health platforms with pilot programs and partnerships in US healthcare sector.
Growth metrics
As a publicly traded company, stock performance is a public metric; specific revenue or user metrics for subsidiaries are not consistently disclosed.
Market positioning
Positions as a publicly-traded investment vehicle (CSE: AIML) providing access to a curated portfolio of early-stage ventures in digital health and AI/ML markets, focusing on commercialization and scaling.
Geographic focus
Primarily North America, headquartered in Vancouver, with a strategic focus on the large US healthcare market.
Patents and IP
Patents pending for personal health monitoring and management systems developed by subsidiary Health Gauge.
About Paul Duffy
Over 30 years of leadership experience in digital technologies, with a strong background in the commercialization of AI, AR, and hologram technologies. Previously, he was President and Chairman of NexTech3D.AI and Co-founder and CEO of ARHT Media Inc.
Official website: https://www.aiml.health/